Gloria Garoffolo

Mrs. Gloria Garoffolo

Unità di Ingegneria Tissutale Cardiovascolare; Centro Cardiologico Monzino, IRCCS; Milan, Italy
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2019 in Cells
Verified
Journal Article
Open access
PDF file
GGGloria Garoffolo
Gloria Garoffolo
Maurizio PesceMaurizio Pesce
Maurizio Pesce
With the term ‘mechanotransduction’, it is intended the ability of cells to sense and respond to mechanical forces by activating intracellular signal transduction pathways and the relative phenotypic adaptation. While a known role of mechanical stimuli has been acknowledged for developmental biology processes and morphogenesis in various organs, the response of cells to mechanical cues is now also emerging as a major pathophysiology determinant. Cells of the cardiovascular system are typically exposed to a variety of mechanical stimuli ranging from compression to strain and flow (shear) stress. In addition, these cells can also translate subtle changes in biophysical characteristics of the surrounding matrix, such as the stiffness, into intracellular activation cascades with consequent evolution toward pro-inflammatory/pro-fibrotic phenotypes. Since cellular mechanotransduction has a potential readout on long-lasting modifications of the chromatin, exposure of the cells to mechanically altered environments may have similar persisting consequences to those of metabolic dysfunctions or chronic inflammation. In the present review, we highlight the roles of mechanical forces on the control of cardiovascular formation during embryogenesis, and in the development and pathogenesis of the cardiovascular system.

31 August 2022 in Acta Biomaterialia
Verified
Journal Article
Closed access
SRSara Ragazzini
Sara Ragazzini
FSFranca Scocozza
Franca Scocozza
GBGiacomo Bernava
Giacomo Bernava
FAFerdinando Auricchio
Ferdinando Auricchio
Gualtiero Ivanoe ColomboGualtiero Ivanoe Colombo
Gualtiero Ivanoe Colombo
GGGloria Garoffolo
Gloria Garoffolo

10 March 2021 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
AAAlessandra Amendola
Alessandra Amendola
GGGloria Garoffolo
Gloria Garoffolo
PSPaola Songia
Paola Songia
Roberta NardacciRoberta Nardacci
Roberta Nardacci
SFSilvia Ferrari
Silvia Ferrari
Maurizio PesceMaurizio Pesce
Maurizio Pesce
Patients with severe respiratory syndrome caused by SARS-CoV-2 undergo cardiac complications due to hyper-inflammatory conditions. Although the presence of the virus has been detected in the myocardium of infected patients, and infection of induced pluripotent cell-derived cardiomyocytes has been demonstrated, the reported expression of Angiotensin-Converting Enzyme-2 (ACE2) in cardiac stromal cells suggests that SARS-CoV-2 may determine cardiac injury by sustaining productive infection and increasing inflammation. We analysed expression of ACE2 receptor in primary human cardiac stromal cells derived from cardiospheres, using proteomics and transcriptomics before exposing them to SARS-CoV-2 in vitro. Using conventional and high sensitivity PCR methods, we measured virus release in the cellular supernatants and monitored the intracellular viral bioprocessing. We performed high-resolution imaging to show the sites of intracellular viral production and demonstrated the presence of viral particles in the cells with electron microscopy. We finally used RT–qPCR assays to detect genes linked to innate immunity and fibrotic pathways coherently regulated in cells after exposure to the virus. Our findings indicate that cardiac stromal cells are susceptible to SARS-CoV-2 infection and produce variable viral yields depending on the extent of cellular ACE2 receptor expression. Interestingly, these cells also evolved towards hyper-inflammatory/pro-fibrotic phenotypes independently of ACE2 levels. Thus, SARS-CoV-2 infection of myocardial stromal cells could be involved in cardiac injury and explain the high number of complications observed in severe cases of COVID-19.

25 May 2021 in Current Research in Pharmacology and Drug Discovery
Verified
Journal Article
Open access
GGGloria Garoffolo
Gloria Garoffolo
Maurizio PesceMaurizio Pesce
Maurizio Pesce
Cardiac fibrosis is characterized by extracellular matrix deposition in the cardiac interstitium, and this contributes to cardiac contractile dysfunction and progression of heart failure. The main players involved in this process are the cardiac fibroblasts, which, in the presence of pro-inflammatory/pro-fibrotic stimuli, undergo a complete transformation acquiring a more proliferative, a pro-inflammatory and a secretory phenotype. This review discusses the cellular effectors and molecular pathways implicated in the pathogenesis of cardiac fibrosis and suggests potential strategies to monitor the effects of specific drugs designed to slow down the progression of this disease by specifically targeting the fibroblasts.

7 October 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
GGGloria Garoffolo
Gloria Garoffolo
SFSilvia Ferrari
Silvia Ferrari
SRStefano Rizzi
Stefano Rizzi
MBMarianna Barbuto
Marianna Barbuto
GBGiacomo Bernava
Giacomo Bernava
Maurizio PesceMaurizio Pesce
Maurizio Pesce
The ability of the cells to sense mechanical cues is an integral component of ”social” cell behavior inside tissues with a complex architecture. Through ”mechanosensation” cells are in fact able to decrypt motion, geometries and physical information of surrounding cells and extracellular matrices by activating intracellular pathways converging onto gene expression circuitries controlling cell and tissue homeostasis. Additionally, only recently cell mechanosensation has been integrated systematically as a crucial element in tissue pathophysiology. In the present review, we highlight some of the current efforts to assess the relevance of mechanical sensing into pathology modeling and manufacturing criteria for a next generation of cardiovascular tissue implants.

Verified
Journal Article
Open access
PDF file
RHReem Saud Al Hejailan
Reem Saud Al Hejailan
GGGloria Garoffolo
Gloria Garoffolo
VRVineesh Vimala Raveendran
Vineesh Vimala Raveendran
Maurizio PesceMaurizio Pesce
Maurizio Pesce
After more than 20 years following the introduction of regenerative medicine to address the problem of cardiac diseases, still questions arise as to the best cell types and materials to use to obtain effective clinical translation. Now that it is definitively clear that the heart does not have a consistent reservoir of stem cells that could give rise to new myocytes, and that there are cells that could contribute, at most, with their pro-angiogenic or immunomodulatory potential, there is fierce debate on what will emerge as the winning strategy. In this regard, new developments in somatic cells’ reprogramming, material science and cell biophysics may be of help, not only for protecting the heart from the deleterious consequences of aging, ischemia and metabolic disorders, but also to boost an endogenous regeneration potential that seems to be lost in the adulthood of the human heart.